Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

SLM

Sallie Mae Appoints Two New Board Members

Sallie Mae (NASDAQ: SLM) has announced the appointment of two new members to its board of directors, effective April 23, 2025. Dr. Daniel Greenstein, the Managing Director of Higher Education at Baker Tilly (US), brings extensive experience in higher education strategy, innovation, and transformation to the board. Prior to his current position, he served as the Chancellor of the Pennsylvania State System of Higher Education and held a leadership role at the Bill & Melinda Gates Foundation.

Mr. Gary Millerchip, the Executive Vice President and Chief Financial Officer at Costco Wholesale Corporation, also joins the board, bringing decades of experience in finance, retail banking, and corporate strategy. His previous roles include senior leadership positions at the Kroger Co. and the Royal Bank of Scotland.

According to Carter Franke, Chair of the Board of Directors at Sallie Mae, the addition of Dr. Greenstein and Mr. Millerchip is expected to complement and deepen the expertise and skills of the board, helping the company advance its strategic priorities and deliver value for customers and shareholders.

These appointments reflect a strategic move by Sallie Mae to leverage the expertise of these accomplished leaders to drive the company's growth and success in the higher education finance and banking sectors. As a result of these announcements, the company's shares have moved -1.4% on the market, and are now trading at a price of $27.75. For more information, read the company's full 8-K submission here.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS